SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study

Descripción del Articulo

This study was supported by FONDECYT (Fondo Nacional de Ciencia y Tecnología, Peru), code: 071-2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Detalles Bibliográficos
Autores: Huamaní C., Velásquez L., Montes S., Mayanga-Herrera A., Bernabé-Ortiz A.
Formato: artículo
Fecha de Publicación:2021
Institución:Consejo Nacional de Ciencia Tecnología e Innovación
Repositorio:CONCYTEC-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.concytec.gob.pe:20.500.12390/3052
Enlace del recurso:https://hdl.handle.net/20.500.12390/3052
https://doi.org/10.7717/peerj.12149
Nivel de acceso:acceso abierto
Materia:Seroprevalence
Altitude
COVID
Peru
https://purl.org/pe-repo/ocde/ford#3.03.08
id CONC_b044035beb2d73b75b8115f806a92209
oai_identifier_str oai:repositorio.concytec.gob.pe:20.500.12390/3052
network_acronym_str CONC
network_name_str CONCYTEC-Institucional
repository_id_str 4689
dc.title.none.fl_str_mv SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study
title SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study
spellingShingle SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study
Huamaní C.
Seroprevalence
Altitude
Altitude
COVID
Peru
https://purl.org/pe-repo/ocde/ford#3.03.08
title_short SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study
title_full SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study
title_fullStr SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study
title_full_unstemmed SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study
title_sort SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study
author Huamaní C.
author_facet Huamaní C.
Velásquez L.
Montes S.
Mayanga-Herrera A.
Bernabé-Ortiz A.
author_role author
author2 Velásquez L.
Montes S.
Mayanga-Herrera A.
Bernabé-Ortiz A.
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Huamaní C.
Velásquez L.
Montes S.
Mayanga-Herrera A.
Bernabé-Ortiz A.
dc.subject.none.fl_str_mv Seroprevalence
topic Seroprevalence
Altitude
Altitude
COVID
Peru
https://purl.org/pe-repo/ocde/ford#3.03.08
dc.subject.es_PE.fl_str_mv Altitude
Altitude
COVID
Peru
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.03.08
description This study was supported by FONDECYT (Fondo Nacional de Ciencia y Tecnología, Peru), code: 071-2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.available.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.issued.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12390/3052
dc.identifier.doi.none.fl_str_mv https://doi.org/10.7717/peerj.12149
dc.identifier.scopus.none.fl_str_mv 2-s2.0-85115293048
url https://hdl.handle.net/20.500.12390/3052
https://doi.org/10.7717/peerj.12149
identifier_str_mv 2-s2.0-85115293048
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv PeerJ
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.publisher.none.fl_str_mv PeerJ Inc.
publisher.none.fl_str_mv PeerJ Inc.
dc.source.none.fl_str_mv reponame:CONCYTEC-Institucional
instname:Consejo Nacional de Ciencia Tecnología e Innovación
instacron:CONCYTEC
instname_str Consejo Nacional de Ciencia Tecnología e Innovación
instacron_str CONCYTEC
institution CONCYTEC
reponame_str CONCYTEC-Institucional
collection CONCYTEC-Institucional
repository.name.fl_str_mv Repositorio Institucional CONCYTEC
repository.mail.fl_str_mv repositorio@concytec.gob.pe
_version_ 1844883129045614592
spelling Publicationrp08753600rp08751600rp08750600rp08752600rp05799600Huamaní C.Velásquez L.Montes S.Mayanga-Herrera A.Bernabé-Ortiz A.2024-05-30T23:13:38Z2024-05-30T23:13:38Z2021https://hdl.handle.net/20.500.12390/3052https://doi.org/10.7717/peerj.121492-s2.0-85115293048This study was supported by FONDECYT (Fondo Nacional de Ciencia y Tecnología, Peru), code: 071-2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Background. There are several ecological studies, but few studies of the prevalence of SARS-COV-2 at high altitude. We aimed to estimate the population-based seroprevalence of SARS-COV-2 in three settings of Cusco at the end of the first wave among adults. Methods. A population-based survey was conducted in September 2020, in three settings in the region of Cusco: (1) Cusco city at 3,300 meters above the sea level (m.a.s.l.), (2) the periphery of Cusco (Santiago, San Jerónimo, San Sebastián, and Wanchaq) at 3,300 m.a.s.l., and (3) Quillabamba city, located at 1,050 m.a.s.l. People aged ? 18 years within a family unit were included. The diagnosis of SARS-CoV-2 infection was based on identifying anti- SARS-CoV-2 total antibodies (IgM and IgG) in serum using the Elecsys Anti-SARS-CoV-2 chemiluminescence test. Results. We enrolled 1924 participants from 712 families. Of the total, 637 participants were anti-SARS-CoV-2 seropositive. Seroprevalence was 38.8% (95% CI [33.4%-44.9%]) in Cusco city, 34.9% (95% CI [30.4%-40.1%]) in the periphery of Cusco, and 20.3% (95% CI [16.2%-25.6%]) in Quillabamba. In 141 families (19.8%; 95% CI [17.0%-22.8%]) the whole members were positive to the test. Living with more than three persons in the same house, a positive COVID-19 case at home, and a member who died in the last five months were factors associated with SARS-COV-2 seropositivity. Dysgeusia/dysosmia was the symptom most associated with seropositivity (aPR = 2.74, 95% CI [2.41-3.12]); whereas always wearing a face shield (aPR = 0. 73; 95% CI [0.60-0.89]) or a facial mask (aPR = 0.76, 95% CI [0.63-0. 92) reduced that probability. Conclusions. A great proportion of Cusco's city inhabitants presented anti-SARS-CoV-2 antibodies at the end of the first wave, with significant differences between settings. Wearing masks and face shields were associated with lower rate of seropositivity; however, efforts must be made to sustain them over time since there is still a high proportion of susceptible people. © 2021 PeerJ Inc.. All rights reserved.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - ConcytecengPeerJ Inc.PeerJinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/4.0/SeroprevalenceAltitude-1Altitude-1COVID-1Peru-1https://purl.org/pe-repo/ocde/ford#3.03.08-1SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional studyinfo:eu-repo/semantics/articlereponame:CONCYTEC-Institucionalinstname:Consejo Nacional de Ciencia Tecnología e Innovacióninstacron:CONCYTEC20.500.12390/3052oai:repositorio.concytec.gob.pe:20.500.12390/30522024-05-30 16:13:32.175https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_14cbinfo:eu-repo/semantics/closedAccessmetadata only accesshttps://repositorio.concytec.gob.peRepositorio Institucional CONCYTECrepositorio@concytec.gob.pe#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="f3e4dae7-71f2-4e68-b453-b003a40398eb"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study</Title> <PublishedIn> <Publication> <Title>PeerJ</Title> </Publication> </PublishedIn> <PublicationDate>2021</PublicationDate> <DOI>https://doi.org/10.7717/peerj.12149</DOI> <SCP-Number>2-s2.0-85115293048</SCP-Number> <Authors> <Author> <DisplayName>Huamaní C.</DisplayName> <Person id="rp08753" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Velásquez L.</DisplayName> <Person id="rp08751" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Montes S.</DisplayName> <Person id="rp08750" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Mayanga-Herrera A.</DisplayName> <Person id="rp08752" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Bernabé-Ortiz A.</DisplayName> <Person id="rp05799" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>PeerJ Inc.</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by-nc-nd/4.0/</License> <Keyword>Seroprevalence</Keyword> <Keyword>Altitude</Keyword> <Keyword>Altitude</Keyword> <Keyword>COVID</Keyword> <Keyword>Peru</Keyword> <Abstract>Background. There are several ecological studies, but few studies of the prevalence of SARS-COV-2 at high altitude. We aimed to estimate the population-based seroprevalence of SARS-COV-2 in three settings of Cusco at the end of the first wave among adults. Methods. A population-based survey was conducted in September 2020, in three settings in the region of Cusco: (1) Cusco city at 3,300 meters above the sea level (m.a.s.l.), (2) the periphery of Cusco (Santiago, San Jerónimo, San Sebastián, and Wanchaq) at 3,300 m.a.s.l., and (3) Quillabamba city, located at 1,050 m.a.s.l. People aged ? 18 years within a family unit were included. The diagnosis of SARS-CoV-2 infection was based on identifying anti- SARS-CoV-2 total antibodies (IgM and IgG) in serum using the Elecsys Anti-SARS-CoV-2 chemiluminescence test. Results. We enrolled 1924 participants from 712 families. Of the total, 637 participants were anti-SARS-CoV-2 seropositive. Seroprevalence was 38.8% (95% CI [33.4%-44.9%]) in Cusco city, 34.9% (95% CI [30.4%-40.1%]) in the periphery of Cusco, and 20.3% (95% CI [16.2%-25.6%]) in Quillabamba. In 141 families (19.8%; 95% CI [17.0%-22.8%]) the whole members were positive to the test. Living with more than three persons in the same house, a positive COVID-19 case at home, and a member who died in the last five months were factors associated with SARS-COV-2 seropositivity. Dysgeusia/dysosmia was the symptom most associated with seropositivity (aPR = 2.74, 95% CI [2.41-3.12]); whereas always wearing a face shield (aPR = 0. 73; 95% CI [0.60-0.89]) or a facial mask (aPR = 0.76, 95% CI [0.63-0. 92) reduced that probability. Conclusions. A great proportion of Cusco&apos;s city inhabitants presented anti-SARS-CoV-2 antibodies at the end of the first wave, with significant differences between settings. Wearing masks and face shields were associated with lower rate of seropositivity; however, efforts must be made to sustain them over time since there is still a high proportion of susceptible people. © 2021 PeerJ Inc.. All rights reserved.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication> -1
score 13.377223
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).